Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
KUALA LUMPUR, Malaysia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced the conclusion of its Equity Line of Credit (ELOC)...
-
Charlotte, NC, Dec. 09, 2025 (GLOBE NEWSWIRE) -- FG Nexus Inc. (Nasdaq: FGNX, FGNXP) (the “Company”), today announced that its Board of Directors has approved a preferred share repurchase program to...
-
Charlotte, NC, Dec. 08, 2025 (GLOBE NEWSWIRE) -- FG Nexus Inc. (Nasdaq: FGNX, FGNXP) (the “Company”), today announced the appointment of Scott D. Wollney as Lead Independent Director of the...
-
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- ReserveOne, Inc. (“ReserveOne”) and ReserveOne Holdings, Inc. (“Pubco”) today announced that, in connection with the previously disclosed proposed...
-
GIG HARBOR, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- IP Strategy (Nasdaq: IPST) (the “Company”), the first company to adopt a treasury reserve policy centered on the $IP token, releases its monthly...
-
ROAD TOWN, British Virgin Islands, Nov. 27, 2025 (GLOBE NEWSWIRE) -- YZi Labs Management Ltd. (“YZi Labs”, or “we”), a significant stockholder of CEA Industries Inc. (“BNC” or the “Company”), today...
-
KUALA LUMPUR, Malaysia, Nov. 26, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced the acquisition of approximately 4 million additional OOB...
-
We are entering a transformative phase for the Company as we work on building our digital asset base and strengthening our balance sheet
-
FORT LAUDERDALE, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Stewards Inc. (OTC: FAVO), a diversified financial company operating across private credit, real assets and digital finance, today...
-
We aim to leverage our public company platform to build a diversified digital asset portfolio while continuing to advance our innovative oncology pipeline.